Botulinum toxin type a for the treatment of urinary tract dysfunction in neurological disorders
O'Leary, M.; Dierich, M.
Urologic Nursing 30(4): 228-234
2010
ISSN/ISBN: 1053-816X PMID: 20949807 Document Number: 639704
Botulinum toxin type A injections represent an important therapeutic option for patients with neurogenic urinary dysfunction in whom conservative treatment has not been effective. The nurse's role in ensuring that these patients receive appropriate assessment and treatment is discussed.
Document emailed within 1 workday
Related Documents
Von Lindern, J.J. 2001: Type a botulinum toxin in the treatment of chronic facial pain associated with temporo-mandibular dysfunction Acta Neurologica Belgica 101(1): 39-412013: Botulinum toxin type A and neurogenic urinary incontinence: sometimes beneficial, if used safely Prescrire International 22(134): 12-13
Chuang, Y-Chi.; Smith, C.P.; Somogyi, G.T.; Chancellor, M.B. 2003: Botulinum toxin treatment of urethral and bladder dysfunction Journal of the Formosan Medical Association 102(1): 5-11
Brin, M.F. 1991: Interventional neurology: treatment of neurological conditions with local injection of botulinum toxin Archivos de Neurobiologia 54(5): 173-189
Woolery-Lloyd, H.; Elsaie, M.L.; Avashia, N. 2008: Inguinal hyperhidrosis misdiagnosed as urinary incontinence: treatment with botulinum toxin a Journal of Drugs in Dermatology: Jdd 7(3): 293-295
Al-Ahmad, H.T.; Al-Qudah, M.A. 2006: The treatment of masseter hypertrophy with botulinum toxin type A Saudi Medical Journal 27(3): 397-400
Comella, C.L.; Jankovic, J.; Brin, M.F. 2000: Use of botulinum toxin type a in the treatment of cervical dystonia Neurology 55(12 Suppl 5: S15-S21
Belin, E.E.; Polo, J. 2003: Treatment of compensatory hyperhidrosis with botulinum toxin type a Cutis 71(1): 68-70
Rusciani, L.; Severino, E.; Rusciani, A. 2002: Type a botulinum toxin: a new treatment for axillary and palmar hyperhidrosis Journal of Drugs in Dermatology: Jdd 1(2): 147-151
Strobl, W. 2001: Botulinum toxin type a in the treatment plan for cerebral palsy Wiener Klinische Wochenschrift 113(Suppl 4): 30-35
Anosov, I.I.; Bulatova, T.I. 1983: Morphological and histochemical reactions of an organism to the administration of Clostridium botulinum toxin. IX. Reactions of the neurons of the abducens nerve nucleus and of the Darkshevich's nucleus to the administration of C. botulinum type B toxin Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 2: 101-105
Günther, O.; Bitterlich, N. 2011: Treatment of myofascial pain syndrome (MPS) with botulinum toxin type a (BoNT-A) MMW Fortschritte der Medizin 153(Suppl 2): 64-69
Monheit, G.; Lin, X.; Nelson, D.; Kane, M. 2012: Consideration of muscle mass in glabellar line treatment with botulinum toxin type a Journal of Drugs in Dermatology: Jdd 11(9): 1041-1045
Kouris, A.; Vavouli, C.; Markantoni, V.; Kontochristopoulos, G. 2014: Muscle weakness in treatment of palmar hyperhidrosis with botulinum toxin type a: can it be prevented? Journal of Drugs in Dermatology: Jdd 13(11): 1315-1316
Wolswijk, A.H.M.; Dirkx, A.E.M. 2015: Treatment of spasticity in nursing homes: botulinum toxin type a as part of therapy Nederlands Tijdschrift Voor Geneeskunde 159: A7833
Glaser, D.A. 2004: Treatment of axillary hyperhidrosis by chemodenervation of sweat glands using botulinum toxin type a Journal of Drugs in Dermatology: Jdd 3(6): 627-631
Shetty, S.; Dawes, P.; Ruske, D.; Al-qudah, M.; Lyons, B. 2006: Botulinum toxin type-A (Botox-A) injections for treatment of sialorrhoea in adults: a New Zealand study New Zealand Medical Journal 119(1240): U2129
Dykstra, D.D.; Presthus, J. 2006: Botulinum toxin type A for the treatment of provoked vestibulodynia: an open-label, pilot study Journal of Reproductive Medicine 51(6): 467-470
Rubin, M.G.; Dover, J.; Glogau, R.G.; Goldberg, D.J.; Goldman, M.P.; Schlessinger, J. 2009: The efficacy and safety of a new U.S. Botulinum toxin type a in the retreatment of glabellar lines following open-label treatment Journal of Drugs in Dermatology: Jdd 8(5): 439-444
Cohen, J.L.; Dayan, S.H. 2006: Botulinum toxin type a in the treatment of dermatochalasis: an open-label, randomized, dose-comparison study Journal of Drugs in Dermatology: Jdd 5(7): 596-601